DXR
Daxor Corporation
NASDAQ: DXR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$10.17
-4.39% today
Updated 2026-06-05
Market cap
$61.88M
P/E ratio
6.46
P/S ratio
2,318.84x
EPS (TTM)
$1.64
Dividend yield
—
52W range
$8 – $15
Volume
0.0M
Daxor Corporation (DXR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
-74.4%
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-06-30 | $0.00 | $-0.07 | — | $18348.00 | -74.4% |
| 2025-03-31 | $0.00 | $0.00 | — | — | — |
| 2024-12-31 | $0.00 | $0.43 | — | $695307.00 | +743.3% |
| 2024-09-30 | $0.00 | $0.00 | — | — | — |
| 2024-06-30 | $0.00 | $0.00 | — | $71756.00 | -11.4% |
| 2024-03-31 | $0.00 | $0.00 | — | $35878.00 | -11.4% |
| 2023-12-31 | $0.00 | $0.00 | — | $82448.00 | -14.5% |
| 2023-09-30 | $0.00 | $0.00 | — | $41224.00 | -14.5% |
| 2023-06-30 | $0.00 | $0.00 | — | $80974.00 | — |
| 2023-03-31 | $0.00 | $0.00 | — | $40487.00 | — |
| 2022-12-31 | $0.00 | $1.54 | — | $96398.00 | — |
| 2022-09-30 | $0.00 | $0.00 | — | $48199.00 | — |
Frequently asked questions
Has Daxor Corporation beaten earnings estimates?
Daxor Corporation has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.
What is Daxor Corporation's revenue growth rate?
Daxor Corporation reported year-over-year revenue growth of -74.4% in its most recent quarter. Reading revenue growth alongside margins shows whether that growth is translating into profit.